MEDGENOME

MedGenome is a genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome. Our powerful genomics solutions accelerate biomarker identification and discovery research for pharma and biotech companies. Our unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level to facilitate research in personalized healthcare. MedGenome Inc. has its Corporate Headquarters and a Next Generation Sequencing (NGS) lab in Foster City, California, US. MedGenome Inc. offers Next-Generation Sequencing based genomic solutions in cancer immunotherapy and metabolic diseases. Its unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level, to facilitate research in personalized health care. MedGenome Labs is the market leader for genetic diagnostic testing in India and South Asia, applying Next Generation Sequencing (NGS) techniques to large disease cohorts in cancer, eye and neurological disorders, diabetes, cardiovascular diseases and rare cancers. Our NGS lab in Bangalore is the highest throughput lab in South-East Asia. We offer more than 400 genetic tests across different disease areas such as Oncology, Neurology, Cardiology, Ophthalmology and Rare diseases. MedGenome is the only NGS facility in the country to be validated and verified to run the highly accurate and comprehensive non-invasive prenatal test (Panorama). MedGenome has two state-of-the-art sequencing labs – A 10,000 sq. ft. in Bangalore and 5000 sq. ft. lab in Cochin – the only company in India to do so. MedGenome has recently purchased the Illumina NovaSeq platform to fuel its genomic research services capability. Our dedicated team of biologists, bioinformaticians and statisticians analyze omics data to enable research projects by global pharma and biotech.